Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference StudiesADVANCES IN THERAPYIF42022-12-015OAAI
OVERVIEW OF EVIDENCE REVIEW GROUP CRITIQUE OF METHODS USED ACROSS CLINICAL EFFECTIVENESS SLRS WITHIN NICE STA COMPANY SUBMISSIONSVALUE IN HEALTHIF62019-05-010OAAI
Variation in the apparent importance of health-related problems with the instrument used to measure patient welfareQUALITY OF LIFE RESEARCHIF2.72018-08-186PREAI
Sharing and the Provision of Cost-Ineffective Life-Extending Services to Less Severely Ill PatientsVALUE IN HEALTHIF62018-08-013OAAI
Uncertainty and the Undervaluation of Services for Severe Health States in Cost-Utility AnalysesVALUE IN HEALTHIF62018-07-013OAAI
Social preferences for prioritising the treatment of disabled and chronically ill patients: beyond the order effecthealth economicsIF3.32018-05-083PREAI
Does the use of the proportional shortfall help align the prioritisation of health services with public preferences?EUROPEAN JOURNAL OF HEALTH ECONOMICSIF32017-08-115OA
Social preferences for prioritizing the treatment of severely ill patients: The relevance of severity, expected benefit, past health and lifetime healthHEALTH POLICYIF3.42017-08-014OAAI
Assessing the validity of the ICECAP-A capability measure for adults with depressionBMC PSYCHIATRYIF3.62017-02-0240OAAI
THE EUROPEAN SOCIAL PREFERENCE MEASUREMENT (ESPM) STUDY: CONCEPTUAL CONSIDERATIONS AND IMPLEMENTATIONVALUE IN HEALTHIF62016-11-010PREAI
How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrumentEUROPEAN JOURNAL OF HEALTH ECONOMICSIF32016-07-2514PREAI
Age Weights for Health Services Derived from the Relative Social Willingness-to-Pay InstrumentMEDICAL DECISION MAKINGIF2.32016-07-109PREAI
Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based dataQUALITY OF LIFE RESEARCHIF2.72016-06-25104PREAI
Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease AreasMEDICAL DECISION MAKINGIF2.32015-11-1864PREAI
Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39DIABETES RESEARCH AND CLINICAL PRACTICEIF7.42015-08-0119PREAI
INTERVENTIONS FOR ULTRA-RARE DISORDERS (URDS) AND THE LOGIC OF COST EFFECTIVENESSVALUE IN HEALTHIF62015-05-011OAAI
Why do multi-attribute utility instruments produce different utilities: the relative importance of the descriptive systems, scale and 'micro-utility' effectsQUALITY OF LIFE RESEARCHIF2.72015-01-3185OAAI
Can Multi-attribute Utility Instruments Adequately Account for Subjective Well-being?MEDICAL DECISION MAKINGIF2.32015-01-2627PREAI
THE EVALUATION OF ECONOMIC METHODS TO ASSESS THE SOCIAL VALUE OF MEDICAL INTERVENTIONS FOR ULTRA-RARE DISORDERS (URDS)VALUE IN HEALTHIF62014-11-010OAAI